Filing Details

Accession Number:
0000939767-19-000158
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-08-02 20:27:39
Reporting Period:
2019-08-01
Accepted Time:
2019-08-02 20:27:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
939767 Exelixis Inc. EXEL Services-Commercial Physical & Biological Research (8731) 043257395
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1202102 A George Scangos C/O Exelixis, Inc.
1851 Harbor Bay Parkway
Alameda CA 94502
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-08-01 33,950 $20.48 1,134,081 No 4 S Direct
Common Stock Disposition 2019-08-01 6,050 $21.23 1,128,031 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 8,963 Indirect By Trust (JS)
Common Stock 8,963 Indirect By Trust (KS)
Common Stock 5,669 Indirect By 401(k) Plan
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 24, 2018.
  2. Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $19.85 to $20.76. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
  3. Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.88 to $21.59. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4.
  4. Shares held by George A. Scangos and Leslie S. Wilson, as Trustees of the Jennifer Scangos Trust.
  5. Shares held by George A. Scangos and Leslie S. Wilson, as Trustees of the Katherine Scangos Trust.
  6. Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of July 31, 2019.